arBtrage CAPITALIZING MARKETS checking… Sign in

Bicara Therapeutics Inc.

BCAX Health Care Biotechnology: Pharmaceutical Preparations
$20.00
▼ -2.0% Today
as of Jun 7, 07:10 ET
Last 30 days -8.76% Apr 28 → Jun 05
$18.93 $20.23 $21.54 $22.84 $24.14 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$20.28
High
$20.42
Low
$19.95
Volume
$347,493
Avg Vol
$553,654
Mkt Cap
$1.4B
P/E (TTM)
Beta
52w High
$24.25
52w Low
$8.48
Div Yield
Shares Out
$66M

Overview

52-week range
$8.48
$24
73% of range
Avg surprise (last 2)
-57.7%
Avg reaction (last 2)
-3.3%
50% positive
Latest IV / EM
117%
EM ±16.3% · $20 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-38.23$-28.77$-19.31$-9.86$-0.40 Actual $-38.23Actual $-18.94Actual $-19.01Actual $-1.60Actual $-0.68Est $-0.40Actual $-0.50Actual $-0.67Actual $-0.93Est $-0.64 SepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-56M$-47M$-37M$-27M$-18M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon May 11, 2026Mar/2026 $-0.93 $-0.64 -45.3% -36.8% +1.5% earnings
Tue Sep 30, 2025Sep 2025 $-0.67 financials
Mon Jun 30, 2025Jun 2025 $-0.50 financials
Tue May 13, 2025Mar/2025 $-0.68 $-0.40 -70.0% -8.1% earnings
Mon Sep 30, 2024Sep 2024 $-1.60 financials
Sun Jun 30, 2024Jun 2024 $-19.01 financials
Sun Mar 31, 2024Mar 2024 $-18.94 financials
Sat Sep 30, 2023Sep 2023 $-38.23 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-60M$-41M$-32M$-42M$-21M$-20M
Net income$-56M$-36M$-27M$-37M$-17M$-17M
EPS (diluted)$-0.93$-0.67$-0.50$-0.68$-1.60$-19.01

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$323M$97M$172M$437M$462M$490M$521M
Inventory
Total current assets$545M$422M$297M$444M$471M$503M$522M
Total assets$554M$431M$425M$454M$478M$510M$524M
Long-term debt
Total liabilities$40M$30M$22M$18M$19M$18M$15M
Total equity$514M$401M$403M$435M$459M$492M$510M$-175M

Implied volatility — last 90 days

112%114%117%119%122% Jun 07 — IV 117% · EM ±16.2%

Sector peers